Skip to main content
Article thumbnail
Location of Repository

Distinct functional defect of three novel Brugada syndrome related cardiac sodium channel mutations

By Chia-Hsiang Hsueh, Wen-Pin Chen, Jiunn-Lee Lin, Chia-Ti Tsai, Yen-Bin Liu, Jyh-Ming Juang, Hsuan-Ming Tsao, Ming-Jai Su and Ling-Ping Lai

Abstract

The Brugada syndrome is characterized by ST segment elevation in the right precodial leads V1-V3 on surface ECG accompanied by episodes of ventricular fibrillation causing syncope or even sudden death. The molecular and cellular mechanisms that lead to Brugada syndrome are not yet completely understood. However, SCN5A is the most well known responsible gene that causes Brugada syndrome. Until now, more than a hundred mutations in SCN5A responsible for Brugada syndrome have been described. Functional studies of some of the mutations have been performed and show that a reduction of human cardiac sodium current accounts for the pathogenesis of Brugada syndrome. Here we reported three novel SCN5A mutations identified in patients with Brugada syndrome in Taiwan (p.I848fs, p.R965C, and p.1876insM). Their electrophysiological properties were altered by patch clamp analysis. The p.I848fs mutant generated no sodium current. The p.R965C and p.1876insM mutants produced channels with steady state inactivation shifted to a more negative potential (9.4 mV and 8.5 mV respectively), and slower recovery from inactivation. Besides, the steady state activation of p.1876insM was altered and was shifted to a more positive potential (7.69 mV). In conclusion, the SCN5A channel defect related to Brugada syndrome might be diverse but all resulted in a decrease of sodium current

Topics: Research
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:2653527
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. (1999). AA: A single Na(+) channel mutation causing both long-QT and Brugada syndromes. Circ Res
    2. (2006). AA: Common sodium channel promoter haplotype in asian subjects underlies variability in cardiac conduction. Circulation
    3. (2003). AAM: Genetic control of sodium channel function. Cardiovascular research
    4. (2008). Bezzina CR: Sodium channel beta1 subunit mutations associated with Brugada syndrome and cardiac conduction disease in humans. The Journal of clinical investigation
    5. (2003). Chahine M: A novel mutation in SCN5A, delQKP 1507–1509 causing long QT syndrome: role of Q1507 residue in sodium channel inactivation. Journal of molecular and cellular cardiology
    6. (2005). Electrophysiological basis and genetics of Brugada syndrome.
    7. (2002). Expression and intracellular localization of an SCN5A double mutant R1232W/T1620M implicated in Brugada syndrome. Circ Res
    8. (2001). Gating-dependent mechanisms for flecainide action in SCN5A-linked arrhythmia syndromes. Circulation
    9. (1998). Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature
    10. (1999). Jr: Congenital long-QT syndrome caused by a novel mutation in a conserved acidic domain of the cardiac Na+ channel. Circulation
    11. (2005). Jr: Inherited disorders of voltage-gated sodium channels.
    12. (2002). Kitabatake A: A mutant cardiac sodium channel with multiple biophysical defects associated with overlapping clinical features of Brugada syndrome and cardiac conduction disease. Cardiovascular research
    13. (2008). Kucera JP: Analyses of a novel SCN5A mutation (C1850S): conduction vs. repolarization disorder hypotheses in the Brugada syndrome. Cardiovascular research
    14. (2007). Loss-of-Function Mutations in the Cardiac Calcium Channel Underlie a New Clinical Entity Characterized by ST-Segment Elevation, Short QT Intervals, and Sudden Cardiac Death. Circulation
    15. (2004). Nav1.5 E1053K mutation causing Brugada syndrome blocks binding to ankyrin-G and expression of Nav1.5 on the surface of cardiomyocytes.
    16. (2000). PJ: Clinical and Genetic Heterogeneity of Right Bundle Branch Block and ST-Segment Elevation Syndrome: A Prospective Evaluation of 52 Families. Circulation
    17. (2007). Priori SG: The Brugada syndrome. Current opinion in cardiology
    18. (2001). RS: Inherited Brugada and long QT-3 syndrome mutations of a single residue of the cardiac sodium channel confer distinct channel and clinical phenotypes. The Journal of biological chemistry
    19. (2002). RS: Secondary structure of the human cardiac Na+ channel C terminus: evidence for a role of helical structures in modulation of channel inactivation. The Journal of biological chemistry
    20. (2004). RS: Structural Effects of an LQT-3
    21. (2004). RS: The Na+ Channel Inactivation Gate Is a Molecular Complex: A Novel Role of the COOH-terminal Domain.
    22. (2007). SK: A novel mutation in the SCN5A gene is associated with Brugada syndrome. Life sciences
    23. (2006). Sodium Channel Inactivation in Heart: A Novel Role of the Carboxy-Terminal Domain. Journal of cardiovascular electrophysiology
    24. (2006). T: Modulation of Nav1.5 channel function by an alternatively spliced sequence in the DII/DIII linker region. The Journal of biological chemistry
    25. (2001). The cardiac sodium channel: gating function and molecular pharmacology. Journal of molecular and cellular cardiology

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.